|Bid||320.41 x 3100|
|Ask||322.51 x 3100|
|Day's Range||320.74 - 324.15|
|52 Week Range||268.25 - 326.88|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.25%|
To target patients across communities, Abiomed (ABMD) has been developing a hub-and-spoke model with hospitals.
Investment company Pachira Investments Inc. buys Vanguard Short-Term Bond, sells SPDR MidCap Trust Series I during the 3-months ended 2017-06-30, according to the most recent filings of the investment ...
In 2016, United Therapeutics’ (UTHR) Tyvaso reported revenues of ~$404.0 million, which reflected an ~15.0% decline year-over-year.